Uğur Şahin, BioNTech CEO (Photo by: Andreas Arnold/picture-alliance/dpa/AP Images)

BioN­Tech delves in­to AD­Cs with $170M up­front weeks af­ter Pfiz­er lines up Seagen

As its Covid vac­cine part­ner Pfiz­er goes all in on the hot field of an­ti­body-drug con­ju­gates, BioN­Tech will en­ter the space as well in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.